McMaster University researchers using MediPharm Labs CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-controlled trial using cannabis- oil for treatment of insomnia in major depressive disorder.
Among those with depression, 75% have difficulty falling or staying asleep - according to John Hopkins Medicine. MediPharm Labs and the McMaster Research Team hope CBD50 and/or CBD10:2 provides these patients with relief from this condition.
BARRIE, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (MediPharm Labs or the Company) a pharmaceutical company specialized in cannabis, is pleased to announce that the Companys research partner McMaster University (the Researcher) has received a no objection letter from Health Canada to proceed with research with MediPharm Labs CBD50 and CBD10:2. This is a key milestone in moving forward with the Companys strategy to be the go-to cannabis partner for pharmaceuticals containing cannabis.
This phase 2 trial is a pilot, double-blind, randomized, placebo-controlled trial that will be evaluating the efficacy and safety of a cannabis-oil for the treatment of insomnia in major depressive disorder. The study is being conducted by a clinical research group led by Dr. Benicio Frey, Professor, McMaster University and Psychiatrist, St. Josephs Healthcare Hamilton. As North America has made progress in diagnosing and eliminating the stigma around mental health, more patients are looking for therapeutic treatment options.
The Researchers believe that cannabidiol (CBD) with or without THC could be effective in the treatment of sleep disorders related to depression. In order to prove this efficacy, a high quality, dosable and standardize formulation is needed for clinical trial material. MediPharm Labs will use its Cannabis Drug Licence and Drug Establishment Licence to provide access to clinical trial material that meets these pharmaceutical quality standards and Good Manufacturing Practices (GMP), as well as provide investigative protocol and regulatory approval support.
Story continues
As a pharmaceutical company specialized in cannabis, MediPharm Labs is encouraged by the ongoing research and development of drugs containing cannabis. This study will create opportunities to show efficacy in our already commercialized cannabis oil while also making progress on our long-term goal to manufacture pharmaceutical drugs containing cannabinoids as an active ingredient, said Keith Strachan, President and Interim CEO, MediPharm Labs.
Many individuals around the world are using cannabinoids to treat their sleep problems without robust clinical evidence from placebo-controlled trials. This study is, therefore, a major step towards evidence-based research investigating the efficacy and safety of CBD and CBD/THC in the treatment of insomnia in those who suffer from depression, said Dr. Benicio Frey.
The is the second approval of its kind for a clinical trial with McMaster. A trial lead by a separate clinician group received a letter of no objection in June 2021 to proceed with using MediPharm Labs CBD50 for a randomized trial studying the effect of cannabidiol vs. placebo on persistent post-surgical pain following total knee arthroplasty.
The Company looks forward to progressing both these active trials with the respective researchers while using its GMP Drug Establishment License and Health Canada Cannabis Drug License to supply API and finished goods to others development pharmaceutical drugs with marketing authorization.
About MediPharm Labs
Founded in 2015, MediPharm Labs is a pharmaceutical company that specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with four primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and completed commercialization of its Australian extraction facility which generated its first revenues in H1 2020. MediPharm Labs Australia was established in 2017.
Cautionary Note Regarding Forward-Looking Information:
This news release contains forward-looking information and forward-looking statements (collectively, forward-looking statements) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as expects, or does not expect, is expected, anticipates or does not anticipate, plans, budget, scheduled, forecasts, estimates, believes or intends or variations of such words and phrases or stating that certain actions, events or results may or could, would, might or will be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, the successful performance of the clinical trials as planned; being the go-to cannabis partner for pharmaceuticals containing cannabis; the creation of opportunities to show efficacy in the Companys already commercialized cannabis oil; progress on the Companys long-term goal to manufacture pharmaceutical drugs containing cannabinoids as an active ingredient; and the development of pharmaceutical drugs containing cannabis. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs filings, available on the SEDAR website at http://www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
See the original post here:
- 10 Best CBD Gummies (April 2024) Forbes Health - Forbes - April 14th, 2024 [April 14th, 2024]
- Best CBD for Seniors: Top 6 Options to Explore - Healthnews.com - April 14th, 2024 [April 14th, 2024]
- Green Acres CBD Gummies Review: Scam or Worth the Money? - The Daily World - April 14th, 2024 [April 14th, 2024]
- Best CBD for Sleep in 2024: Gummies, Oils and More - Healthline - April 14th, 2024 [April 14th, 2024]
- Can you fly with weed? Everything you should know ahead of 4/20 - The Points Guy - April 14th, 2024 [April 14th, 2024]
- 8 Best CBD Gummies for Anxiety in 2024 - Healthline - April 14th, 2024 [April 14th, 2024]
- Radiant Ease CBD Gummies Review (Scam or Legit?) What to Know First! - Bothell-Kenmore Reporter - April 14th, 2024 [April 14th, 2024]
- Oregon Mom Treated Teen Daughter's Liver Cancer with CBD Oil, Gets 90 Days in Jail - PEOPLE - March 2nd, 2024 [March 2nd, 2024]
- This CBD business's Amish CEO wants to make Lancaster a hemp haven - The Philadelphia Inquirer - March 2nd, 2024 [March 2nd, 2024]
- Companies Were Big on CBD. Not Anymore. - The New York Times - March 2nd, 2024 [March 2nd, 2024]
- Mom who treated daughter's cancer with CBD oil instead of chemo, surgery gets 90 days in jail - CTV News - March 2nd, 2024 [March 2nd, 2024]
- Oregon mom Christine Dixon who tried to treat teen daughter's cancer with CBD oil is sentenced to 90 days in p - Daily Mail - March 2nd, 2024 [March 2nd, 2024]
- Mom who treated daughters cancer with CBD oil instead of chemo, surgery gets 90 days in jail - KCTV 5 - March 2nd, 2024 [March 2nd, 2024]
- Oregon mom who treated daughters cancer with CBD oil instead of chemo, surgery gets 90 days in jail - Fox 12 Oregon - March 2nd, 2024 [March 2nd, 2024]
- Mom who treated daughters cancer with CBD oil instead of chemo, surgery gets 90 days in jail - KGNS - March 2nd, 2024 [March 2nd, 2024]
- 10 Best CBD Oils Of March 2024 Forbes Health - Forbes - March 2nd, 2024 [March 2nd, 2024]
- Mother treats daughter's liver cancer with CBD oil - FOX 26 Houston - March 2nd, 2024 [March 2nd, 2024]
- Mom who gave daughter CBD oil for cancer treatment sentenced - KGW.com - March 2nd, 2024 [March 2nd, 2024]
- Cannabis oil found to be effective treatment for canine discoid lupus erythematosus - Phys.org - March 2nd, 2024 [March 2nd, 2024]
- Mother treats daughter's liver cancer with CBD oil - Yahoo News - March 2nd, 2024 [March 2nd, 2024]
- Oregon Mom Is Now Going to Jail After Treating Young Daughter's Liver Cancer With CBD Oil - CafeMom - March 2nd, 2024 [March 2nd, 2024]
- Best CBD Tinctures for 2024 - Healthline - March 2nd, 2024 [March 2nd, 2024]
- Peak 8 CBD Gummies Reviews (Dr Oz Bliss Bites CBD Gummies THC) Hoax Or Real Peak 8 CBD Must Read & Where To Buy Peak 8? - The Week - March 2nd, 2024 [March 2nd, 2024]
- CBD and cycling: significant performance claims, but proceed with caution - CyclingWeekly - March 2nd, 2024 [March 2nd, 2024]
- Top 4 Benefits of Using CBD Oil - Emagazine.com - E/The Environmental Magazine - February 27th, 2024 [February 27th, 2024]
- The Top 8 CBD Brands of 2024: Tested by Healthline Editors - Healthline - February 27th, 2024 [February 27th, 2024]
- Florida CBD retailers worry statewide hemp legislation will crush them - Business Observer - February 27th, 2024 [February 27th, 2024]
- FIVE Palm Jumeirah has launched a CBD oil massage: here's what it's like... - What's On Dubai - February 27th, 2024 [February 27th, 2024]
- Slim CBD - Cannabis is increasingly used in weight management and fitness-related products - Trend Hunter - February 27th, 2024 [February 27th, 2024]
- What is full-spectrum CBD? Benefits, types, uses, and risks - TravelDailyNews International - TravelDailyNews International - February 27th, 2024 [February 27th, 2024]
- Greenville CBD retailers are clearing shelves amid crackdown on hemp products with THC - Greenville News - February 27th, 2024 [February 27th, 2024]
- 10 Best CBD Capsules For 2024 Forbes Health - Forbes - February 27th, 2024 [February 27th, 2024]
- CBD Store vs. CBD Dispensary : Which One is Better? - Qrius - February 27th, 2024 [February 27th, 2024]
- Curing Pets With Cannabis as Veterinarians Try CBD and THC - The New York Times - February 9th, 2024 [February 9th, 2024]
- Danish dog owners are medicating their pets with unlicensed cannabis products is it safe? - The Conversation - February 9th, 2024 [February 9th, 2024]
- Long-term CBD for dogs caused few health problems - PetfoodIndustry.com - February 9th, 2024 [February 9th, 2024]
- CBD Oil Market to grow by USD 5.36 billion from 2022 to 2027; Aurora Cannabis Inc. and BIOTA Biosciences LLC ... - PR Newswire - February 9th, 2024 [February 9th, 2024]
- Medallion Green CBD Gummies Reviews: Legit Shark Tank CBD Official? - Deccan Herald - February 9th, 2024 [February 9th, 2024]
- 10 Best CBD Creams Of 2024 Forbes Health - Forbes - February 9th, 2024 [February 9th, 2024]
- Is CBD Bedding Legit Or Just A Gimmick? The Experts And I Weigh In - Forbes - February 9th, 2024 [February 9th, 2024]
- Companies can't say Delta-9 is in their food or drinks in SC | Business - The Post and Courier - January 27th, 2024 [January 27th, 2024]
- Global CBD Consumer Health Market Analysis & Forecast 2024-2034: Government Reforms and Growing Awareness ... - GlobeNewswire - January 27th, 2024 [January 27th, 2024]
- More people are using CBD products. There's still little research on the benefits and risks - KPRC Click2Houston - December 16th, 2023 [December 16th, 2023]
- Naternal Review: Are These CBD Gummies & Oils Worth It? - mindbodygreen - December 16th, 2023 [December 16th, 2023]
- Pet Wellness Redefined: The Benefits of CBD Oil - Orange Fizz - December 16th, 2023 [December 16th, 2023]
- 6 CBD Oils for Joint Pain and Arthritis - Healthline - December 16th, 2023 [December 16th, 2023]
- 7 Best CBD Tinctures for Inflammation in 2023 - Healthline - December 16th, 2023 [December 16th, 2023]
- Vigor Vita CBD Gummies Reviews Beware! Is It Legit? - Carolina Huddle - December 16th, 2023 [December 16th, 2023]
- Green Vibe CBD Gummies Reviews SCAM EXPOSED in Real Consumer GreenVibe CBD Gummies Reports - Carolina Huddle - December 16th, 2023 [December 16th, 2023]
- Global CBD Market to Hit $36B Over Next Decade, Report Predicts - High Times - December 16th, 2023 [December 16th, 2023]
- Top 6 CBD Edibles to Buy Online in 2023 - Washington City Paper - December 16th, 2023 [December 16th, 2023]
- Cbd Products Fda Best Place To Buy Cbd Oil Gummies - University of New Haven - December 12th, 2023 [December 12th, 2023]
- Harmony Leaf CBD Gummies Review: Shocking Scam to Avoid or Legit Gummy? - Bellevue Reporter - December 12th, 2023 [December 12th, 2023]
- 14 Best CBD Lube and Arousal Gel Options of 2024 - Cosmopolitan - December 12th, 2023 [December 12th, 2023]
- Pain Relief Cbd Athlete - Choose the University of New Haven - University of New Haven - December 12th, 2023 [December 12th, 2023]
- Revive CBD Gummies Reviewed - Serious Warning Before Buy! | Vashon-Maury Island Beachcomber - Vashon-Maury Island Beachcomber - December 12th, 2023 [December 12th, 2023]
- When is the best time to take cbd oil in 2023? - DISCOVER Magazine - August 26th, 2023 [August 26th, 2023]
- Reasons For The Evolvement Of CBD Vape Oil In Modern Times - chimpreports.com - August 26th, 2023 [August 26th, 2023]
- Analyzing CBD studies: Health concerns, health claims, populations ... - Nutritional Outlook - August 26th, 2023 [August 26th, 2023]
- USDA Doubles The Number Of Hemp Professionals Serving On ... - Marijuana Moment - August 26th, 2023 [August 26th, 2023]
- I was a National Champion with the Florida Gators and played in NFL now I run my own CBD oil business... - The US Sun - August 26th, 2023 [August 26th, 2023]
- The ABCs of CBD: Cannabinoids in Dermatology and Skin Care - Dermatology Times - August 26th, 2023 [August 26th, 2023]
- Exploring the Connection: Does CBD Help with Depression and How? - babyboomers.com - August 26th, 2023 [August 26th, 2023]
- Hulk Hogan reveals why he quit drinking alcohol - Yahoo Eurosport UK - August 26th, 2023 [August 26th, 2023]
- Best Male Enhancement Gummies 2023: Compare the Top-Rated ... - Kirkland Reporter - August 26th, 2023 [August 26th, 2023]
- 'We are all we have': CBD business struggles - The Bay's News First - SunLive - August 26th, 2023 [August 26th, 2023]
- 8 Best CBD Oils For Cats With Anxiety - mindbodygreen - June 20th, 2023 [June 20th, 2023]
- CBD Oil Market to Reach USD 55,791.3 Million by 2028 | With - GlobeNewswire - June 20th, 2023 [June 20th, 2023]
- Using TLC-MS for the Direct Analysis of CBD - AZoM - June 20th, 2023 [June 20th, 2023]
- Cornbread Hemp Organic CBD Gummies Review - BusinessMole - June 20th, 2023 [June 20th, 2023]
- Revenant's Heaterz Infused Pre-rolls launching at all SWADE ... - Greenway - June 20th, 2023 [June 20th, 2023]
- Three people arrested and 400 cannabis plants seized at ... - The Isle of Thanet News - June 20th, 2023 [June 20th, 2023]
- Maya Jama in Bathing Suit Shares a Special Selfie - Celebwell - June 20th, 2023 [June 20th, 2023]
- ABSTRAX Releases White Paper That Details Its Role in Keeping ... - PR Web - June 20th, 2023 [June 20th, 2023]
- CBD For Inflammation: Does It Really Work? Forbes Health - Forbes - May 18th, 2023 [May 18th, 2023]
- CBDfx Review: We Tested 5 Top Products, Expert Reviewed | mindbodygreen - mindbodygreen - May 18th, 2023 [May 18th, 2023]
- 5 Benefits of CBD, According To Research & Experts - mindbodygreen - May 18th, 2023 [May 18th, 2023]
- CBD Oil Market size, Witness Highest Growth in near future by 2030 ... - Cottonwood Holladay Journal - May 18th, 2023 [May 18th, 2023]
- As Seen On TV: Fusion CBD Products Are Appearing On The Big ... - Herb.co - May 18th, 2023 [May 18th, 2023]
- An "Explosion" Of CBD Awesomeness, Or Just Another Dud ... - LA Weekly - May 18th, 2023 [May 18th, 2023]